• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-149-3p 通过靶向 AKT2 抑制口腔鳞状细胞癌的细胞增殖。

MicroRNA‑149‑3p inhibits cell proliferation by targeting AKT2 in oral squamous cell carcinoma.

机构信息

Department of Stomatology Center, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 518100, P.R. China.

出版信息

Mol Med Rep. 2021 Mar;23(3). doi: 10.3892/mmr.2020.11811. Epub 2021 Jan 5.

DOI:10.3892/mmr.2020.11811
PMID:33398370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7821286/
Abstract

MicroRNAs (miRs) exhibit oncogenic or tumor suppressive functions that contribute to the initiation and development of various types of human cancer. miR‑149‑3p has been reported to serve multiple roles in the regulation of proliferation, apoptosis and metastasis. However, the effects and detailed mechanism of miR‑149‑3p in oral squamous cell carcinoma (OSCC) remain unclear. In the present study, miR‑149‑3p mimic, mimic control, miR‑149‑3p inhibitor and inhibitor control were transiently transfected into Cal27 and SCC‑9 cells. The viability, proliferation and apoptosis of OSCC cells were determined using Cell Counting Kit‑8, colony formation and Annexin V assays, respectively. The mRNA expression levels of miR‑149‑3p and AKT2 were determined by reverse transcription‑quantitative PCR. The protein expression levels of AKT2, cleaved caspase‑3 and cleaved PARP were examined by western blot analysis. The binding of miR‑149‑3p to the AKT2 3'‑untranslated region was evaluated by a dual luciferase reporter assay. In the present study, overexpression of miR‑149‑3p reduced the viability and proliferation of OSCC cells. By contrast, increased cell viability and proliferation was observed in miR‑149‑3p‑deficient OSCC cells. Dual luciferase reporter assay indicated that miR‑149‑3p significantly decreased the luciferase activity of the wild‑type AKT2 3'‑untranslated region. Moreover, overexpression of miR‑149‑3p downregulated the mRNA and protein expression levels of AKT2, suggesting that miR‑149‑3p was a negative modulator of AKT2. Restoration of AKT2 efficiently reversed the miR‑149‑3p‑mediated reduction in the proliferative capacity of OSCC cells. In addition, miR‑149‑3p enhanced the sensitivity of OSCC cells to the chemotherapeutic drug 5‑fluorouracil. Taken together, the current findings revealed an inhibitory effect of miR‑149‑3p on the proliferation of OSCC cells through the post‑transcriptional suppression of AKT2, and indicated a potential chemosensitizing function of miR‑149‑3p for the treatment of patients with OSCC.

摘要

微小 RNA(miRs)具有致癌或肿瘤抑制功能,有助于各种类型人类癌症的发生和发展。已经报道 miR-149-3p 在调节增殖、凋亡和转移方面具有多种作用。然而,miR-149-3p 在口腔鳞状细胞癌(OSCC)中的作用和详细机制尚不清楚。在本研究中,瞬时转染 miR-149-3p 模拟物、模拟物对照、miR-149-3p 抑制剂和抑制剂对照到 Cal27 和 SCC-9 细胞中。通过 Cell Counting Kit-8、集落形成和 Annexin V 测定分别确定 OSCC 细胞的活力、增殖和凋亡。通过逆转录-定量 PCR 测定 miR-149-3p 和 AKT2 的 mRNA 表达水平。通过 Western blot 分析检测 AKT2、cleaved caspase-3 和 cleaved PARP 的蛋白表达水平。通过双荧光素酶报告基因检测评估 miR-149-3p 与 AKT2 3'UTR 的结合。在本研究中,miR-149-3p 的过表达降低了 OSCC 细胞的活力和增殖。相反,在 miR-149-3p 缺陷的 OSCC 细胞中观察到细胞活力和增殖增加。双荧光素酶报告基因检测表明,miR-149-3p 显著降低了野生型 AKT2 3'UTR 的荧光素酶活性。此外,miR-149-3p 的过表达下调了 AKT2 的 mRNA 和蛋白表达水平,表明 miR-149-3p 是 AKT2 的负调节剂。AKT2 的恢复有效地逆转了 miR-149-3p 介导的 OSCC 细胞增殖能力的降低。此外,miR-149-3p 增强了 OSCC 细胞对化疗药物 5-氟尿嘧啶的敏感性。总之,目前的研究结果揭示了 miR-149-3p 通过 AKT2 的转录后抑制对 OSCC 细胞增殖的抑制作用,并表明 miR-149-3p 具有治疗 OSCC 患者的潜在化疗增敏作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/6d2d320610ef/mmr-23-03-11811-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/d99128997095/mmr-23-03-11811-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/17d7ca5282a1/mmr-23-03-11811-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/cffb8260647b/mmr-23-03-11811-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/2f24f36a1afb/mmr-23-03-11811-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/896883d469e2/mmr-23-03-11811-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/15ecf9396033/mmr-23-03-11811-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/6d2d320610ef/mmr-23-03-11811-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/d99128997095/mmr-23-03-11811-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/17d7ca5282a1/mmr-23-03-11811-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/cffb8260647b/mmr-23-03-11811-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/2f24f36a1afb/mmr-23-03-11811-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/896883d469e2/mmr-23-03-11811-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/15ecf9396033/mmr-23-03-11811-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5ac/7821286/6d2d320610ef/mmr-23-03-11811-g06.jpg

相似文献

1
MicroRNA‑149‑3p inhibits cell proliferation by targeting AKT2 in oral squamous cell carcinoma.微小 RNA-149-3p 通过靶向 AKT2 抑制口腔鳞状细胞癌的细胞增殖。
Mol Med Rep. 2021 Mar;23(3). doi: 10.3892/mmr.2020.11811. Epub 2021 Jan 5.
2
MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.微小 RNA-186 通过负向调控蛋白酪氨酸磷酸酶 SHP2 的表达在口腔鳞状细胞癌中发挥肿瘤抑制作用。
Arch Oral Biol. 2018 May;89:20-25. doi: 10.1016/j.archoralbio.2018.01.016. Epub 2018 Jan 31.
3
LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.长链非编码RNA UCA1通过抑制miR-184的表达促进口腔鳞状细胞癌的增殖和顺铂耐药。
Cancer Med. 2017 Dec;6(12):2897-2908. doi: 10.1002/cam4.1253. Epub 2017 Nov 10.
4
MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A.miR-487a-3p 通过靶向 PPM1A 抑制口腔鳞状细胞癌的生长和侵袭。
Bioengineered. 2021 Dec;12(1):937-947. doi: 10.1080/21655979.2021.1884396.
5
MicroRNA-378-3p/5p represses proliferation and induces apoptosis of oral squamous carcinoma cells via targeting KLK4.miRNA-378-3p/5p 通过靶向 KLK4 抑制口腔鳞状细胞癌细胞增殖并诱导其凋亡。
Clin Exp Pharmacol Physiol. 2020 Apr;47(4):713-724. doi: 10.1111/1440-1681.13235. Epub 2020 Jan 20.
6
Macrophage‑derived exosomes attenuate the susceptibility of oral squamous cell carcinoma cells to chemotherapeutic drugs through the AKT/GSK‑3β pathway.巨噬细胞来源的外泌体通过 AKT/GSK-3β 通路减弱口腔鳞状细胞癌细胞对化疗药物的敏感性。
Oncol Rep. 2020 Nov;44(5):1905-1916. doi: 10.3892/or.2020.7748. Epub 2020 Sep 2.
7
CircLPAR3 Acts as an Oncogene in Oral Squamous Cell Carcinoma Through Regulating the miR-643/HMGB2 Network.环状 RNA LPAR3 通过调控 miR-643/HMGB2 网络在口腔鳞状细胞癌中发挥癌基因作用。
Biochem Genet. 2022 Jun;60(3):882-898. doi: 10.1007/s10528-021-10134-y. Epub 2021 Sep 15.
8
MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.miR-92a 通过 Wnt/β-catenin 信号通路抑制口腔鳞状细胞癌细胞的增殖并促进其凋亡。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4803-4809. doi: 10.26355/eurrev_202005_21169.
9
Lung cancer‑associated transcript 1 facilitates tumorigenesis in laryngeal squamous cell carcinoma through the targeted inhibition of miR‑493.肺癌相关转录本 1 通过靶向抑制 miR-493 促进喉鳞状细胞癌的发生。
Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11697. Epub 2020 Nov 20.
10
MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.微小 RNA-199a-5p 通过抑制 EMT 相关转录因子 SOX4 抑制口腔鳞状细胞癌的迁移和侵袭。
Int J Mol Med. 2019 Jul;44(1):185-195. doi: 10.3892/ijmm.2019.4174. Epub 2019 Apr 25.

引用本文的文献

1
The relationship between oral burns and oral squamous cell carcinoma: a systematic review.口腔烧伤与口腔鳞状细胞癌之间的关系:一项系统综述。
Ann Med Surg (Lond). 2025 Mar 28;87(5):2896-2903. doi: 10.1097/MS9.0000000000003194. eCollection 2025 May.
2
miR-149-3p targeting regulates the sensitivity to cisplatin to inhibit the progression of lung cancer.靶向调控的miR-149-3p可调节对顺铂的敏感性,从而抑制肺癌进展。
Biomol Biomed. 2024 Dec 11;25(1):165-176. doi: 10.17305/bb.2024.11163.
3
Quercetin promotes the proliferation, migration, and invasion of trophoblast cells by regulating the miR-149-3p/AKT1 axis.

本文引用的文献

1
Cell-Autonomous versus Systemic Akt Isoform Deletions Uncovered New Roles for Akt1 and Akt2 in Breast Cancer.细胞自主与系统性 Akt 同工型缺失揭示 Akt1 和 Akt2 在乳腺癌中的新作用。
Mol Cell. 2020 Oct 1;80(1):87-101.e5. doi: 10.1016/j.molcel.2020.08.017. Epub 2020 Sep 14.
2
A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.一个 microRNA 标志物可识别胰腺导管腺癌患者发生淋巴结转移的风险。
Gastroenterology. 2020 Aug;159(2):562-574. doi: 10.1053/j.gastro.2020.04.057. Epub 2020 May 4.
3
Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism.
槲皮素通过调节 miR-149-3p/AKT1 轴促进滋养层细胞的增殖、迁移和侵袭。
Kaohsiung J Med Sci. 2024 Oct;40(10):903-915. doi: 10.1002/kjm2.12887. Epub 2024 Aug 20.
4
AKT2 modulates astrocytic nicotine responses .AKT2调节星形胶质细胞对尼古丁的反应。
bioRxiv. 2024 Jun 1:2024.05.31.596856. doi: 10.1101/2024.05.31.596856.
5
Harnessing tetrahedral framework nucleic acids for enhanced delivery of microRNA-149-3p: A new frontier in oral squamous cell carcinoma therapy.利用四面体框架核酸增强 miR-149-3p 的递送:口腔鳞状细胞癌治疗的新前沿。
Cell Prolif. 2024 Aug;57(8):e13637. doi: 10.1111/cpr.13637. Epub 2024 Apr 26.
6
Ginsenoside Rg3 inhibits the malignant progression of cervical cancer cell by regulating AKT2 expression.人参皂苷Rg3通过调节AKT2表达抑制宫颈癌细胞的恶性进展。
Heliyon. 2023 Aug 9;9(8):e19045. doi: 10.1016/j.heliyon.2023.e19045. eCollection 2023 Aug.
7
Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives.细胞外囊泡在肌萎缩侧索硬化症中的最新进展及新的研究视角。
Cells. 2023 Jul 1;12(13):1763. doi: 10.3390/cells12131763.
8
The Circular RNA circFOXK2 Enhances the Tumorigenesis of Non-Small Cell Lung Cancer Through the miR-149-3p/IL-6 Axis.环状 RNA circFOXK2 通过 miR-149-3p/IL-6 轴促进非小细胞肺癌的肿瘤发生。
Biochem Genet. 2024 Feb;62(1):95-111. doi: 10.1007/s10528-023-10394-w. Epub 2023 May 31.
9
MicroRNA-149-3p expression correlates with outcomes of adrenocortical tumor patients and affects proliferation and cell cycle progression of H295A adrenocortical cancer cell line.miR-149-3p 的表达与肾上腺皮质肿瘤患者的预后相关,并且影响 H295A 肾上腺皮质癌细胞系的增殖和细胞周期进程。
Hum Cell. 2022 Nov;35(6):1952-1960. doi: 10.1007/s13577-022-00778-2. Epub 2022 Sep 2.
10
miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.miR-149-3p是子宫体子宫内膜癌潜在的预后生物标志物,且与免疫浸润相关。
Int J Endocrinol. 2022 Jun 8;2022:5006123. doi: 10.1155/2022/5006123. eCollection 2022.
无 Drosha 依赖的 miR-6778-5p 通过调节细胞质一碳叶酸代谢来增强胃癌干细胞干性。
Cancer Lett. 2020 May 28;478:8-21. doi: 10.1016/j.canlet.2020.02.040. Epub 2020 Mar 4.
4
MiR-149-5p regulates cisplatin chemosensitivity, cell growth, and metastasis of oral squamous cell carcinoma cells by targeting TGFβ2.微小RNA-149-5p通过靶向转化生长因子β2调控口腔鳞状细胞癌细胞的顺铂化疗敏感性、细胞生长和转移。
Int J Clin Exp Pathol. 2019 Oct 1;12(10):3728-3739. eCollection 2019.
5
Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p/S100A4/p53 axis.过表达的甲基转移酶样1(METTL1)通过调节miR-149-3p/S100A4/p53轴增加结肠癌细胞对顺铂的化疗敏感性。
Aging (Albany NY). 2019 Dec 20;11(24):12328-12344. doi: 10.18632/aging.102575.
6
miR-149-3p reverses CD8 T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells.miR-149-3p 通过减少抑制性受体并促进乳腺癌细胞细胞因子分泌来逆转 CD8 T 细胞耗竭。
Open Biol. 2019 Oct 31;9(10):190061. doi: 10.1098/rsob.190061. Epub 2019 Oct 9.
7
MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2.微小 RNA-194 通过抑制 AKT2 使肝星状细胞失活并减轻肝纤维化。
World J Gastroenterol. 2019 Aug 21;25(31):4468-4480. doi: 10.3748/wjg.v25.i31.4468.
8
LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.LINC00472通过MicroRNA-149-3p和MicroRNA-4270,经由KLLN介导的p53信号通路在非小细胞肺癌中发挥肿瘤抑制作用。
Mol Ther Nucleic Acids. 2019 Sep 6;17:563-577. doi: 10.1016/j.omtn.2019.06.003. Epub 2019 Jun 15.
9
Association of rs1353058818 and rs1053004 gene polymorphisms with human tongue squamous cell carcinoma.rs1353058818 和 rs1053004 基因多态性与人类舌鳞癌的相关性。
Biosci Rep. 2019 Jul 23;39(7). doi: 10.1042/BSR20190955. Print 2019 Jul 31.
10
Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.Akt 在口腔鳞状细胞癌中的异构体特异性作用。
Biomolecules. 2019 Jun 27;9(7):253. doi: 10.3390/biom9070253.